Page last updated: 2024-10-29

ketanserin and Neuroendocrine Tumors

ketanserin has been researched along with Neuroendocrine Tumors in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Neuroendocrine Tumors: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drozdov, I1
Kidd, M1
Gustafsson, BI1
Svejda, B1
Joseph, R1
Pfragner, R1
Modlin, IM1

Other Studies

1 other study available for ketanserin and Neuroendocrine Tumors

ArticleYear
Autoregulatory effects of serotonin on proliferation and signaling pathways in lung and small intestine neuroendocrine tumor cell lines.
    Cancer, 2009, Nov-01, Volume: 115, Issue:21

    Topics: Cell Line, Tumor; Cell Proliferation; Homeostasis; Humans; Intestinal Neoplasms; JNK Mitogen-Activat

2009